SL Science

SLBTNasdaq Taiwan Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$1.497 B

$2.67 -2.20%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances) — ranked by market cap

All 160 →

#38ImmunocoreIMCR$1.64B
#39Maze TherapeuticsMAZE$1.59B
#40SL ScienceSLBT$1.50B
#41Vir BiotechnologyVIR$1.49B
#42Monte Rosa TherapeuticsGLUE$1.34B

Where these numbers come from

Share counts and financials for SL Science are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.